Prognostic value of IGFBP2 in various cancers: a systematic review and meta-analysis.
Biao ZhangChao-Qun HongYu-Hao LuoLai-Feng WeiYun LuoYu-Hui PengYi-Wei XuPublished in: Cancer medicine (2022)
The meta-analysis showed that IGFBP2 expression was associated with worse prognosis in several tumors, and may serve as a potential prognostic biomarker in cancer patients.